Style | Citing Format |
---|---|
MLA | Najafzadeh H, et al.. "The Effect of Aspartate-Lysine-Isoleucine and Aspartate-Arginine-Tyrosine Mutations on the Expression and Activity of Vasopressin V2 Receptor Gene." Iranian Biomedical Journal, vol. 14, no. 1-2, 2010, pp. 17-22. |
APA | Najafzadeh H, Safaeian L, Sadeghi HM, Rabbani M, Jafarian A (2010). The Effect of Aspartate-Lysine-Isoleucine and Aspartate-Arginine-Tyrosine Mutations on the Expression and Activity of Vasopressin V2 Receptor Gene. Iranian Biomedical Journal, 14(1-2), 17-22. |
Chicago | Najafzadeh H, Safaeian L, Sadeghi HM, Rabbani M, Jafarian A. "The Effect of Aspartate-Lysine-Isoleucine and Aspartate-Arginine-Tyrosine Mutations on the Expression and Activity of Vasopressin V2 Receptor Gene." Iranian Biomedical Journal 14, no. 1-2 (2010): 17-22. |
Harvard | Najafzadeh H et al. (2010) 'The Effect of Aspartate-Lysine-Isoleucine and Aspartate-Arginine-Tyrosine Mutations on the Expression and Activity of Vasopressin V2 Receptor Gene', Iranian Biomedical Journal, 14(1-2), pp. 17-22. |
Vancouver | Najafzadeh H, Safaeian L, Sadeghi HM, Rabbani M, Jafarian A. The Effect of Aspartate-Lysine-Isoleucine and Aspartate-Arginine-Tyrosine Mutations on the Expression and Activity of Vasopressin V2 Receptor Gene. Iranian Biomedical Journal. 2010;14(1-2):17-22. |
BibTex | @article{ author = {Najafzadeh H and Safaeian L and Sadeghi HM and Rabbani M and Jafarian A}, title = {The Effect of Aspartate-Lysine-Isoleucine and Aspartate-Arginine-Tyrosine Mutations on the Expression and Activity of Vasopressin V2 Receptor Gene}, journal = {Iranian Biomedical Journal}, volume = {14}, number = {1-2}, pages = {17-22}, year = {2010} } |
RIS | TY - JOUR AU - Najafzadeh H AU - Safaeian L AU - Sadeghi HM AU - Rabbani M AU - Jafarian A TI - The Effect of Aspartate-Lysine-Isoleucine and Aspartate-Arginine-Tyrosine Mutations on the Expression and Activity of Vasopressin V2 Receptor Gene JO - Iranian Biomedical Journal VL - 14 IS - 1-2 SP - 17 EP - 22 PY - 2010 ER - |